Literature DB >> 9597386

Diabetes and it's complications in a Swedish county.

B Lundman1, L Engström.   

Abstract

A cross-sectional survey with the aim to study the prevalence of diabetes and long-term complications was carried out in a health care district in Sweden with 125,500 inhabitants. Information was extracted from the medical records. 4127 people with diabetes were identified of whom 87% were classified as NIDDM (non-insulin-dependent diabetes mellitus), 12% as IDDM (insulin-dependent diabetes mellitus) and 0.7% as secondary or unclassified diabetes. The prevalence of diagnosed diabetes was 3.3%. A total of 83% received their regular routine care at primary health care centres, 31% were treated with diet only, 36% had oral hypoglycaemic agents, 31% had insulin and 2% had combination therapy. The mean HbA1c was 7.2% (ref. range 4.0-5.3%). Of the adults (> 18 years) 27% had retinopathy, 13% had nephropathy and 27% had loss of pallaesthesia. 50% had hypertension, 21% angina pectoris, 11% had had myocardial infarction, 11% stroke, 21% had signs of peripheral arterial disease, 2% had been amputated and 21% were smokers. The conclusion is that in a population of patients with diabetes with acceptable metabolic control, complications are still a great problem.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597386     DOI: 10.1016/s0168-8227(97)00128-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden.

Authors:  E Heintz; A-B Wiréhn; B Bourghardt Peebo; U Rosenqvist; L-A Levin
Journal:  Diabetologia       Date:  2010-07-02       Impact factor: 10.122

2.  Incidence of blindness due to diabetic eye disease in Fife 1990-9.

Authors:  T G Cormack; B Grant; M J Macdonald; J Steel; I W Campbell
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

3.  Hypoglycemic Activity of Fumaria parviflora in Streptozotocin-Induced Diabetic Rats.

Authors:  Fatemeh Fathiazad; Sanaz Hamedeyazdan; Mohamad Karim Khosropanah; Arash Khaki
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Costs of diabetes and its complications in Poland.

Authors:  Joanna Leśniowska; Agata Schubert; Michał Wojna; Iwona Skrzekowska-Baran; Marta Fedyna
Journal:  Eur J Health Econ       Date:  2013-07-03

5.  Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients.

Authors:  Mikael K Poulsen; Jan Erik Henriksen; Jordi Dahl; Allan Johansen; Jacob E Møller; Oke Gerke; Werner Vach; Torben Haghfelt; Henning Beck-Nielsen; Poul Flemming Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2009-08-14       Impact factor: 5.952

6.  Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta.

Authors:  Richard T Oster; Shainoor Virani; David Strong; Sandra Shade; Ellen L Toth
Journal:  Can Fam Physician       Date:  2009-04       Impact factor: 3.275

7.  Prevalence of chronic complications in korean patients with type 2 diabetes mellitus based on the korean national diabetes program.

Authors:  Sang Youl Rhee; Suk Chon; Mi Kwang Kwon; Ie Byung Park; Kyu Jeung Ahn; In Ju Kim; Sung-Hoon Kim; Hyoung Woo Lee; Kyung Soo Koh; Doo Man Kim; Sei Hyun Baik; Kwan Woo Lee; Moon Suk Nam; Yong Soo Park; Jeong-Taek Woo; Young Seol Kim
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

8.  Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.

Authors:  Geertje W Dalmeijer; Yvonne T van der Schouw; Elke J Magdeleyns; Cees Vermeer; W M Monique Verschuren; Jolanda M A Boer; Joline W J Beulens
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

9.  Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland.

Authors:  Wojciech Matuszewski; Angelika Baranowska-Jurkun; Magdalena M Stefanowicz-Rutkowska; Robert Modzelewski; Janusz Pieczyński; Elżbieta Bandurska-Stankiewicz
Journal:  Medicina (Kaunas)       Date:  2020-04-06       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.